跳至主要内容
临床试验/NCT00299845
NCT00299845撤回4 期

Randomized Trial for Pharmacogenomics-based Proton Pump Inhibitor Therapy in Children

Osaka University2 个研究点 分布在 1 个国家开始时间: 2006年3月7日最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
撤回
试验地点
2

研究概览

简要总结

Proton pump inhibitors are administered to children as off-label use in Japan. The purpose of this study is to evaluate the effects of CYP2C19 genotypes on pharmacokinetic /pharmacodynamic profiles of PPI in children. The results will provide the beneficial information for the individualized medicine of PPI in children.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
1 Year 至 15 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Patients with gastroesophageal reflux
  • The patient's parent or guardian gives written informed consent including pharmacogenomic analysis
  • The patient is willing and able to give assent to participate.

排除标准

  • Serious hepatic disease, pulmonary disease, renal disease and blood disorder
  • Inadequate clinical conditions

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验